Pfizer Board Member: ‘Natural Immunity’ Against COVID-19 Needs to Be Included in Policy Discussions

Pfizer Board Member: ‘Natural Immunity’ Against COVID-19 Needs to Be Included in Policy Discussions
Then-FDA Commissioner-designate Scott Gottlieb testifies during a Senate Health, Education, Labor, and Pensions Committee hearing on April 5, 2017, at on Capitol Hill. Zach Gibson/Getty Images
Jack Phillips
Updated:
Former Food and Drug Administration Commissioner Scott Gottlieb, who is also a Pfizer board member, noted that “natural immunity” gained from a prior COVID-19 infection needs to be included in discussions about virus-related policies and mandates.

“The balance of the evidence demonstrates that natural immunity confers a durable protection,” Gottlieb said during an Aug. 30 interview, referring to a landmark new preprint Israeli study that found that prior COVID-19 infection confers more protection against the virus than any of the vaccines. “It’s fair to conclude that.”

Jack Phillips
Jack Phillips
Breaking News Reporter
Jack Phillips is a breaking news reporter who covers a range of topics, including politics, U.S., and health news. A father of two, Jack grew up in California's Central Valley. Follow him on X: https://twitter.com/jackphillips5
twitter
Related Topics